Gilead Sciences (GILD) Announces that Teva Pharma (TEVA) Files ANDA with U.S. FDA for Generic Form of Viread
Tweet Send to a Friend
Gilead Sciences, Inc. (NASDAQ: GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
